EndoFLIP logo

Home
About Us
EndoFLIP® Technology
Distributors
Newsroom
Events
Selected Clinical Papers
Contact Us



 

 

GERD

Gastroesophageal reflux disease - GERD

Gastroesophageal reflux disease (GERD) manifests itself as severe heartburn caused by stomach acid refluxing up into the esophagus or the regurgitation of stomach contents back up into the esophagus. Chronic GERD is a prevalent disorder reaching epidemic proportion worldwide, affecting 5-7% of the population daily.

learn more about GERD >>

   
Bariatric

Bariatric Surgery

Approximately 220,000 bariatric procedures were performed in the US in 2008. This is expected to increase to 660,000 procedures worldwide by 2012.

learn more about Bariatric >>

   
Future Markets

Future Markets

Crospon are also reviewing follow-on products for applications in esophageal dilation, as well as esophageal, colonic and pulmonary stent sizing.

 


 
EndoFLIP® Technology
Intro
Benefits
Markets Served
  - GERD >>
  - Bariatric >>
Technology behind EndoFLIP®
Regulatory Details
         
Crospon logo   Crospon®, FLIP® and EndoFLIP® are registered trademarks of Crospon Ltd.